{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:46:26Z","timestamp":1780361186050,"version":"3.54.1"},"reference-count":121,"publisher":"Elsevier","isbn-type":[{"value":"9780443241147","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.pmbts.2024.03.037","type":"book-chapter","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T17:09:53Z","timestamp":1715620193000},"page":"79-105","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the potential of drug repurposing for treating depression"],"prefix":"10.1016","member":"78","reference":[{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.037_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1017\/S2045796018000227","article-title":"Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review","volume":"28","author":"de Zwart","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jad.2017.05.003","article-title":"A systematic review and meta-regression of the prevalence and incidence of perinatal depression","volume":"219","author":"Woody","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib3","article-title":"US Medicaid program: an analysis of the spending and utilization patterns for antidepressants from 2017 to 2021","volume":"13","author":"Elmarasi","year":"2023","journal-title":"Explore Res Clin Soc Pharm"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.03.037_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/neu.2017.39","article-title":"A brief history of antidepressant drug development: from tricyclics to beyond ketamine","volume":"30","author":"Pereira","year":"2018","journal-title":"Acta Neuropsychiatr"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.037_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.sapharm.2007.06.019","article-title":"Utilization, price, and spending trends for antidepressants in the US Medicaid program","volume":"4","author":"Chen","year":"2008","journal-title":"Res Soc Adm Pharm"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.03.037_bib6","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/jphp.12815","article-title":"Drug repurposing may generate novel approaches to treating depression","volume":"69","author":"Ebada","year":"2017","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.037_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"21\u201322","key":"10.1016\/bs.pmbts.2024.03.037_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.drudis.2011.06.010","article-title":"Serological biochemical markers of surrogate efficacy and safety as a novel approach to drug repositioning","volume":"16","author":"Henriksen","year":"2011","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.03.037_bib9","first-page":"4984","article-title":"Unlocking therapeutic potential: integration of drug repurposing and immunotherapy for various disease targeting","volume":"15","author":"Pawar","year":"2023","journal-title":"Am J Transl Res"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-pharmtox-010919-023537","article-title":"using what we already have: uncovering new drug repurposing strategies in existing omics data","volume":"60","author":"Pulley","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.03.037_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028025","article-title":"Systematic drug repositioning based on clinical side-effects","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.03.037_bib12","first-page":"774","article-title":"Drug repurposing for the management of depression: where do we stand currently?","volume":"11","author":"Mohammad Sadeghi","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajp.2014.09.001","article-title":"Emerging antidepressants to treat major depressive disorder","volume":"12","author":"Block","year":"2014","journal-title":"Asian J Psychiatr"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.037_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40263-018-0519-3","article-title":"Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review","volume":"32","author":"Molero","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110050","article-title":"Drug repositioning for treatment-resistant depression: hypotheses from a pharmacogenomic study","volume":"104","author":"Fabbri","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.03.037_bib16","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.drudis.2019.07.007","article-title":"The influence of ketamine on drug discovery in depression","volume":"24","author":"Kraus","year":"2019","journal-title":"Drug Discov Today"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.03.037_bib17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2174\/1570159X18666201015155816","article-title":"5-HT3 receptor antagonism: a potential therapeutic approach for the treatment of depression and other disorders","volume":"19","author":"Bhatt","year":"2021","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.037_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1471-4159.2003.01514.x","article-title":"Functional expression of the norepinephrine transporter in cultured rat astrocytes","volume":"84","author":"Inazu","year":"2003","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.037_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpsychires.2010.06.005","article-title":"Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex","volume":"45","author":"Schipke","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2020.07.011","article-title":"Adrenaline induces calcium signal in astrocytes and vasoconstriction via activation of monoamine oxidase","volume":"159","author":"Novikova","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib21","article-title":"Insulin modulates emotional behavior through a serotonin-dependent mechanism","author":"Martin","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib22","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.4088\/JCP.13r08908","article-title":"Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis","volume":"75","author":"Ogawa","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-022-02389-y","article-title":"Fluoxetine inhibited the activation of A1 reactive astrocytes in a mouse model of major depressive disorder through the astrocytic 5-HT(2B)R\/beta-arrestin2 pathway","volume":"19","author":"Fang","year":"2022","journal-title":"J Neuroinflammation"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT(1A) receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fnl.12.90","article-title":"Astroglia in neurological diseases","volume":"8","author":"Verkhratsky","year":"2013","journal-title":"Future Neurol"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-022-04782-2","article-title":"Spatiotemporal dynamics of noradrenaline during learned behaviour","volume":"606","author":"Breton-Provencher","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib27","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1523\/JNEUROSCI.17-21-08451.1997","article-title":"Reduced levels of norepinephrine transporters in the locus coeruleus in major depression","volume":"17","author":"Klimek","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0028-3908(02)00211-3","article-title":"Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors","volume":"43","author":"Mori","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib29","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.neubiorev.2012.07.011","article-title":"\u03b12 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy","volume":"36","author":"Cottingham","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib30","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archpsyc.1986.01800100048007","article-title":"Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims","volume":"43","author":"Mann","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jad.2014.06.016","article-title":"Increased \u03b12- and \u03b21-adrenoceptor densities in postmortem brains of subjects with depression: differential effect of antidepressant treatment","volume":"167","author":"Rivero","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41386-019-0450-4","article-title":"Astrocytes determine conditioned response to morphine via glucocorticoid receptor-dependent regulation of lactate release","volume":"45","author":"Skupio","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11064-009-0026-5","article-title":"Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats","volume":"35","author":"Rasheed","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib34","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41386-021-01232-x","article-title":"Astrocytes modulate extracellular neurotransmitter levels and excitatory neurotransmission in dorsolateral striatum via dopamine D2 receptor signaling","volume":"47","author":"Adermark","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib35","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.neuropharm.2012.08.007","article-title":"Striatal interaction among dopamine, glutamate and ascorbate","volume":"63","author":"Morales","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.581151","article-title":"Voltage-dependent dopamine potency at D(1)-like dopamine receptors","volume":"11","author":"Agren","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ynstr.2017.02.002","article-title":"Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice","volume":"7","author":"Dostal","year":"2017","journal-title":"Neurobiol Stress"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.037_bib38","first-page":"603","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response. comprehensive","volume":"6","author":"Herman","year":"2016","journal-title":"Physiology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib39","article-title":"Dex modulates the balance of water-electrolyte metabolism by depressing the expression of AVP in PVN","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104831","article-title":"Are the thyroid and adrenal system alterations linked in depression?","volume":"122","author":"Mokrani","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuroscience.2005.05.008","article-title":"Estrogen receptor alpha and beta mRNA expressions by proliferating and differentiating cells in the adult rat dentate gyrus and subventricular zone","volume":"134","author":"Isgor","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib42","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/0024-3205(83)90053-X","article-title":"Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones","volume":"32","author":"Biegon","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib43","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1210\/en.2008-1355","article-title":"Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress","volume":"150","author":"Weiser","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12888-021-03116-2","article-title":"Role of insulin-like growth factor 1, sex and corticosteroid hormones in male major depressive disorder","volume":"21","author":"Arinami","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115742","article-title":"Plasma oxidative stress marker levels related to functional brain abnormalities in first-episode drug-naive major depressive disorder","volume":"333","author":"Liu","year":"2024","journal-title":"Psychiatry Res"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6653309","article-title":"Abnormal default-mode network homogeneity in melancholic and non melancholic major depressive disorder at rest","volume":"2021","author":"Yan","year":"2021","journal-title":"Neural Plast"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00406-015-0614-0","article-title":"Altered functional connectivity density in major depressive disorder at rest","volume":"266","author":"Zhang","year":"2016","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pnpbp.2017.02.001","article-title":"Intrinsic cerebral activity at resting state in adults with major depressive disorder: a meta-analysis","volume":"75","author":"Zhou","year":"2017","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.037_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41398-020-01036-5","article-title":"Common and distinct patterns of intrinsic brain activity alterations in major depression and bipolar disorder: voxel-based meta-analysis","volume":"10","author":"Gong","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-018-1955-9","article-title":"Abnormal resting state activity of left middle occipital gyrus and its functional connectivity in female patients with major depressive disorder","volume":"18","author":"Teng","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.03.037_bib51","article-title":"Hippocampal and Amygdalar Volume Changes in Major Depressive Disorder: A Targeted Review and Focus on Stress","volume":"22","author":"Nolan","year":"2020","journal-title":"Chronic Stress (Thousand Oaks)"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.03.037_bib52","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mp.2016.72","article-title":"Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis","volume":"22","author":"Wise","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.037_bib53","first-page":"174","article-title":"Gene\u2013environment interaction and the genetics of depression","volume":"29","author":"Lesch","year":"2004","journal-title":"J Psychiatry Neurosci"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.037_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.metabol.2005.01.006","article-title":"Genetics and genomics of depression","volume":"54","author":"Hamet","year":"2005","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.037_bib55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.neuron.2014.01.027","article-title":"The genetics of major depression","volume":"81","author":"Flint","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41398-024-02777-3","article-title":"Genome-wide association study implicates the role of TBXAS1 in the pathogenesis of depressive symptoms among the Korean population","volume":"14","author":"Park","year":"2024","journal-title":"Transl Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","article-title":"Epigenetics in Health and Disease","volume":"1253","author":"Zhang","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"10.1016\/bs.pmbts.2024.03.037_bib58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/15592294.2015.1017199","article-title":"Methylation at the CpG island shore region upregulates Nr3c1 promoter activity after early-life stress","volume":"10","author":"Bockm\u00fchl","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib59","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000369585","article-title":"Environmental stressors and epigenetic control of the hypothalamic-pituitary-adrenal axis","volume":"100","author":"Lee","year":"2014","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023881","article-title":"Methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression","volume":"6","author":"Fuchikami","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib61","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1017\/S0954579416000183","article-title":"Maternal mental well-being during pregnancy and glucocorticoid receptor gene promoter methylation in the neonate","volume":"28","author":"Mansell","year":"2016","journal-title":"Dev Psychopathol"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S1461145712000363","article-title":"H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression","volume":"16","author":"Cruceanu","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib63","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yhbeh.2010.09.005","article-title":"Individual differences in the effect of social defeat on anhedonia and histone acetylation in the rat hippocampus","volume":"59","author":"Hollis","year":"2011","journal-title":"Horm Behav"},{"issue":"19","key":"10.1016\/bs.pmbts.2024.03.037_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911245","article-title":"The Microbiota-Gut-Brain Axis in Psychiatric Disorders","volume":"23","author":"G\u00f3ralczyk-Bi\u0144kowska","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.037_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-020-1078-9","article-title":"Gut-brain Axis and migraine headache: a comprehensive review","volume":"21","author":"Arzani","year":"2020","journal-title":"J Headache Pain"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.03.037_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/nu15071752","article-title":"Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive Disorder","volume":"15","author":"Lin","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148644","article-title":"NLRP3 inflammatory pathway. Can we unlock depression?","volume":"1822","author":"Ghaffaripour Jahromi","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/bs.pmbts.2024.03.037_bib68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/imm.12443","article-title":"Immune mechanisms linked to depression via oxidative stress and neuroprogression","volume":"144","author":"Bakunina","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib69","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","article-title":"Association of high-sensitivity C-reactive protein with de novo major depression","volume":"197","author":"Pasco","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","article-title":"Peripheral and central kynurenine pathway abnormalities in major depression","volume":"101","author":"Paul","year":"2022","journal-title":"Brain Behav Immun"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jad.2018.08.015","article-title":"Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors","volume":"242","author":"Wang","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib72","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41419-019-1761-4","article-title":"Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Discord"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib73","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/cns.12230","article-title":"NLRP3 inflammasome: a new target in major depressive disorder","volume":"20","author":"Alcocer-Gomez","year":"2014","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104689","article-title":"Fluoxetine improves behavioural deficits induced by chronic alcohol treatment by alleviating RNA editing of 5-HT(2C) receptors","volume":"134","author":"Li","year":"2020","journal-title":"Neurochem Int"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/jnc.14272","article-title":"The ameliorative effect of fluoxetine on neuroinflammation induced by sleep deprivation","volume":"146","author":"Xia","year":"2018","journal-title":"J Neurochem"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib76","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41467-020-16143-6","article-title":"Plasma membrane damage causes NLRP3 activation and pyroptosis during Mycobacterium tuberculosis infection","volume":"11","author":"Beckwith","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib77","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mp.2016.46","article-title":"Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition","volume":"21","author":"Wong","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib78","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ijnp\/pyx065","article-title":"NLRP3 inflammasome contributes to lipopolysaccharide-induced depressive-like behaviors via indoleamine 2,3-dioxygenase induction","volume":"20","author":"Jeon","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.628144","article-title":"Drug repurposing strategy (DRS): emerging approach to identify potential therapeutics for treatment of novel coronavirus infection","volume":"8","author":"Sahoo","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib80","doi-asserted-by":"crossref","first-page":"1299833","DOI":"10.1080\/20016689.2017.1299833","article-title":"Filling the gap in CNS drug development: evaluation of the role of drug repurposing","volume":"5","author":"Caban","year":"2017","journal-title":"J Mark Access Health Policy"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.037_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/IJPSYM.IJPSYM_228_19","article-title":"Repurposing potential of ketamine: opportunities and challenges","volume":"42","author":"Gautam","year":"2020","journal-title":"Indian J Psychol\u00a0Med"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.03.037_bib82","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.037_bib83","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1109\/JBHI.2018.2856535","article-title":"Drug repositioning for schizophrenia and depression\/anxiety disorders: a machine learning approach leveraging expression data","volume":"23","author":"Zhao","year":"2018","journal-title":"IEEE J Biomed Health Inform"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.037_bib84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.31887\/DCNS.2019.21.3\/trobbins","article-title":"Pharmacological treatment of cognitive deficits in nondementing mental health disorders","volume":"21","author":"Robbins","year":"2019","journal-title":"Dialogues Clin\u00a0Neurosci"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.03.037_bib85","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/pmt-2018-0091","article-title":"Identification of novel analgesics through a drug repurposing strategy","volume":"9","author":"Gazerani","year":"2019","journal-title":"Pain Manag"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.03.037_bib86","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/bph.15753","article-title":"Novel drug developmental strategies for treatment\u2010resistant depression","volume":"179","author":"Borb\u00e9ly","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.037_bib87","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/acps.12957","article-title":"New drug candidates for depression\u2013a nationwide population\u2010based study","volume":"139","author":"Kessing","year":"2019","journal-title":"Acta Psychiatr\u00a0Scand"},{"issue":"7-8","key":"10.1016\/bs.pmbts.2024.03.037_bib88","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/09540261.2022.2113369","article-title":"Statins in depression: a repurposed medical treatment can provide novel insights in mental health","volume":"34","author":"De Giorgi","year":"2022","journal-title":"Int Rev Psychiatry"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.03.037_bib89","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.30367","article-title":"Effect of minocycline on depressive symptoms in patients with treatment-resistant depression: a randomized clinical trial.","volume":"5","author":"Hellmann-Regen","year":"2022","journal-title":"JAMA Network Open"},{"issue":"15","key":"10.1016\/bs.pmbts.2024.03.037_bib90","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jm300576q","article-title":"Predicting new indications for approved drugs using a proteochemometric method","volume":"55","author":"Dakshanamurthy","year":"2012","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.03.037_bib91","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.drudis.2015.08.003","article-title":"Structures of G protein-coupled receptors reveal new opportunities for drug discovery","volume":"20","author":"Cooke","year":"2015","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.037_bib92","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4155\/fmc.13.207","article-title":"Reverse docking: a powerful tool for drug repositioning and drug rescue","volume":"6","author":"Kharkar","year":"2014","journal-title":"Future Med Chem"},{"issue":"20","key":"10.1016\/bs.pmbts.2024.03.037_bib93","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions","volume":"49","author":"Warren","year":"2006","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.037_bib94","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12551-016-0247-1","article-title":"Software for molecular docking: a review","volume":"9","author":"Pagadala","year":"2017","journal-title":"Biophys Rev"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.03.037_bib95","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt.2151","article-title":"Use of genome-wide association studies for drug repositioning","volume":"30","author":"Sanseau","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"Suppl 2","key":"10.1016\/bs.pmbts.2024.03.037_bib96","article-title":"Novel therapeutics for coronary artery disease from genome-wide association study data","volume":"8","author":"Grover","year":"2015","journal-title":"BMC Med Genomics"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.037_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033174","article-title":"Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS One"},{"issue":"R2","key":"10.1016\/bs.pmbts.2024.03.037_bib98","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1093\/hmg\/ddw160","article-title":"Pathway and network-based strategies to translate genetic discoveries into effective therapies","volume":"25","author":"Greene","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib99","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1752-0509-7-139","article-title":"Network based elucidation of drug response: from modulators to targets","volume":"7","author":"Iorio","year":"2013","journal-title":"BMC Syst Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.03.037_bib100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3259","article-title":"Understanding multicellular function and disease with human tissue-specific networks","volume":"47","author":"Greene","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.037_bib101","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/0008-5472.379.65.2","article-title":"Cellular targets of gefitinib","volume":"65","author":"Brehmer","year":"2005","journal-title":"Cancer Res"},{"issue":"6141","key":"10.1016\/bs.pmbts.2024.03.037_bib102","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.03.037_bib103","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"19","key":"10.1016\/bs.pmbts.2024.03.037_bib104","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1158\/1078-0432.CCR-09-1035","article-title":"High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth","volume":"15","author":"Iljin","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.037_bib106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.03.037_bib107","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.9078tx1c","article-title":"A review of the current guidelines for depression treatment","volume":"71","author":"Gelenberg","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib108","article-title":"Evidence synthesis for determining the efficacy of psychotherapy for treatment resistant\u00a0depression","author":"Trivedi","year":"2009","journal-title":"[Internet] Washington (DC): Department of Veterans Affairs (US)"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.037_bib109","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1176\/ajp.2007.164.5.739","article-title":"Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR\u204eD report","volume":"164","author":"Thase","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"9864","key":"10.1016\/bs.pmbts.2024.03.037_bib110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(12)61552-9","article-title":"Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial","volume":"381","author":"Wiles","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.03.037_bib111","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(15)00495-2","article-title":"Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial","volume":"3","author":"Wiles","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.03.037_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.486","article-title":"The treatment of chronic depression with cognitive behavioral analysis system of psychotherapy: a systematic review and meta-analysis of randomized-controlled clinical trials","volume":"6","author":"Negt","year":"2016","journal-title":"Brain Behav"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.037_bib113","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4088\/JCP.13r08815","article-title":"Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis","volume":"75","author":"Gaynes","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib114","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pnpbp.2014.02.004","article-title":"Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis","volume":"51","author":"Ren","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.03.037_bib115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.eurpsy.2012.02.006","article-title":"Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review","volume":"28","author":"Bersani","year":"2013","journal-title":"Eur Psychiatry"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib116","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/521398","article-title":"Magnetic seizure therapy for unipolar and bipolar depression: a systematic review","volume":"2015","author":"Cretaz","year":"2015","journal-title":"Neural Plast"},{"issue":"15","key":"10.1016\/bs.pmbts.2024.03.037_bib117","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1017\/S0033291720003670","article-title":"Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis","volume":"50","author":"Begemann","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/bs.pmbts.2024.03.037_bib118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neubiorev.2015.07.012","article-title":"Transcranial direct current stimulation (tDCS) in the treatment of depression: systematic review and meta-analysis of efficacy and tolerability","volume":"57","author":"Meron","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.03.037_bib119","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.biopsych.2013.10.024","article-title":"Rapid mood-elevating effects of low field magnetic stimulation in depression","volume":"76","author":"Rohan","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.03.037_bib120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/09540261.2011.630993","article-title":"Neurostimulation therapies for treatment resistant depression: a focus on vagus nerve stimulation and deep brain stimulation","volume":"23","author":"Rizvi","year":"2011","journal-title":"Int Rev Psychiatry"},{"issue":"S6","key":"10.1016\/bs.pmbts.2024.03.037_bib121","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.5694\/mja12.10509","article-title":"Non-pharmacological biological treatment approaches to difficult-to-treat depression","volume":"199","author":"Fitzgerald","year":"2013","journal-title":"Med J Aust"}],"container-title":["Progress in Molecular Biology and Translational Science","Clinical Application of Repurposed Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:12:18Z","timestamp":1753355538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117324000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443241147"],"references-count":121,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2024.03.037","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}